First Italian outbreak of VIM-producing<i>Serratia marcescens</i>in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review

Abstract

After three decades of carbapenem antibiotics use, the emergence of carbapenem-resistance in <i>Enterobacteriaceae</i> has become a significant concern and a stricter control to preserve its clinical application is mandatory. This is, to our knowledge, the first outbreak of VIM-producing <i>Serratia marcescens</i> in Europe. Surveillance policies must be implemented to avoid future outbreaks.